Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Aspira Women's Health's total debt was $1.71M at Jun 30, 2026. For fiscal 2025 it was $1.77M, down 16.5% from the year before. Over ten years it grew 4.8% a year on average. The highest annual figure on record is $7.00M in fiscal 2011.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.77M | -16.5% |
| FY2024 | Dec 31, 2024 | $2.12M | -6.4% |
| FY2023 | Dec 31, 2023 | $2.27M | -34.9% |
| FY2022 | Dec 31, 2022 | $3.48M | -5.8% |
| FY2021 | Dec 31, 2021 | $3.70M | -21.9% |
| FY2020 | Dec 31, 2020 | $4.73M | +196.7% |
| FY2019 | Dec 31, 2019 | $1.60M | +7.7% |
| FY2018 | Dec 31, 2018 | $1.48M | -11.1% |
| FY2017 | Dec 31, 2017 | $1.67M | -9.9% |
| FY2016 | Dec 31, 2016 | $1.85M | +67.2% |
| FY2014 | Dec 31, 2014 | $1.11M | 0.0% |
| FY2013 | Dec 31, 2013 | $1.11M | 0.0% |
| FY2012 | Dec 31, 2012 | $1.11M | -84.2% |
| FY2011 | Dec 31, 2011 | $7.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.71M | +10.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.09M | +68.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.77M | -16.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.33M | -14.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.55M | -11.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.83M | -8.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.12M | -6.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.56M | -6.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.75M | -8.1% |
| Q1 FY2024 | Mar 31, 2024 | $2.01M | -36.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.27M | -34.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.67M | -39.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.90M | -38.3% |
| Q1 FY2023 | Mar 31, 2023 | $3.18M | -6.1% |
| Q4 FY2022 | Dec 31, 2022 | $3.48M | -5.8% |
| Q3 FY2022 | Sep 30, 2022 | $2.77M | -6.7% |
| Q2 FY2022 | Jun 30, 2022 | $3.08M | -4.4% |
| Q1 FY2022 | Mar 31, 2022 | $3.39M | +1.8% |
| Q4 FY2021 | Dec 31, 2021 | $3.70M | -21.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.97M | +37.8% |
| Q2 FY2021 | Jun 30, 2021 | $3.22M | +46.3% |
| Q1 FY2021 | Mar 31, 2021 | $3.33M | +167.4% |
| Q4 FY2020 | Dec 31, 2020 | $4.73M | +196.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.15M | +60.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.20M | +58.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.24M | -13.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.60M | +7.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.34M | -12.3% |
| Q2 FY2019 | Jun 30, 2019 | $1.39M | -11.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.43M | -11.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.48M | -11.1% |
| Q3 FY2018 | Sep 30, 2018 | $1.53M | -11.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.57M | -8.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.62M | -8.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.67M | -9.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.72M | -8.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.89M | – |
See a number that looks wrong?